<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00117546</url>
  </required_header>
  <id_info>
    <org_study_id>2004-155</org_study_id>
    <secondary_id>P05.0007L</secondary_id>
    <nct_id>NCT00117546</nct_id>
  </id_info>
  <brief_title>Cardiovascular and Autonomic Reactivity in Women With a History of Pre-eclampsia</brief_title>
  <official_title>Cardiovascular Performance and Autonomic Reactivity in Formerly Preeclamptic Women With a Contracted Plasma Volume (CAPACITY Trial)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Radboud University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Radboud University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A history of preeclampsia is associated with a low plasma volume and higher sympathetic
      activity. Methyldopa will suppress sympathetic activity to normal values. In this study, the
      researchers will test that effect on the total cardiovascular balance.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a randomized double-blind placebo controlled cross-over study in formerly
      preeclamptic women with a contracted plasma volume. The researchers will test the effect of
      methyldopa on the cardiovascular balance and orthostatic tolerance in women with a history of
      preeclampsia and healthy controls.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>September 2005</start_date>
  <completion_date type="Anticipated">December 2008</completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>normalized plasma volume</measure>
    <time_frame>1 month</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>increased orthostatic tolerance</measure>
    <time_frame>1 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>normalized cardiovascular balance</measure>
    <time_frame>1 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>venous capacitance</measure>
    <time_frame>1 month</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">35</enrollment>
  <condition>Preeclampsia</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>alpha methyldopa</intervention_name>
    <description>500 mg twice a day</description>
    <other_name>Aldomet</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Primiparous

          -  History of preeclampsia

          -  Low plasma volume

        Exclusion Criteria:

          -  Thrombophilia

          -  Hypertension

          -  Auto-immune disorder

          -  Insulin dependent diabetes mellitus
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ineke Krabbendam, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Obstetrics and Gynaecology, Radboud University Nijmegen Medical Centre</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>M.E.A Spaanderman, MD, PhD</last_name>
    <phone>+31 24 36 13401</phone>
    <email>m.spaanderman@obgyn.umcn.nl</email>
  </overall_contact>
  <location>
    <facility>
      <name>Radboud University Nijmegen Medical Center</name>
      <address>
        <city>Nijmegen</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>July 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 30, 2005</study_first_submitted>
  <study_first_submitted_qc>June 30, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 7, 2005</study_first_posted>
  <last_update_submitted>June 7, 2010</last_update_submitted>
  <last_update_submitted_qc>June 7, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 8, 2010</last_update_posted>
  <keyword>CAPACITY trial</keyword>
  <keyword>preeclampsia</keyword>
  <keyword>plasma volume</keyword>
  <keyword>sympathetic activity</keyword>
  <keyword>hypertension</keyword>
  <keyword>cardiovascular system</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pre-Eclampsia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Methyldopa</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

